IMU is making tremendous progress and does not need the distractions and disruptions from a consolidation to attempt to influence the share prices.
The share prices will improve based on fda approvals, bp interests, deals, licencing, partnership, etc.
Consolidation will not hasten the progress of the real business of improving IMU's assets ie. Cancer treatments.
not interested in analysing WBT's consolidation and subsequent 'improvements' in its share prices which could have been caused by various factors other than consolidation, like its technologies, deals etc.
cobsoludation is not the answers, efficacy and fda approvals are.
imho.
IMU is making tremendous progress and does not need the...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $396.8M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.3¢ | $537.6K | 10.00M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 207796 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 1452903 | 6 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |